IL10 and lung carcinoma: Our findings demonstrate that CAP treatment could induce M2 polarization of macrophages, trigger IL-10 release, subsequently activate the STAT1/STAT3 signaling pathway to alleviate ER stress caused by CAP, and ultimately suppress the programmed cell death in lung cancer cells, including apoptosis, pyroptosis and autophagy.